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Center, Tokyo Women’s Medical University: Single-Center Experience of 63 Pancreatic Transplantations
Akihito SANNOMIYA１, Ichiro NAKAJIMA１, Kazuhiro IWADOH１, Keiko KUTSUNAI１,
Katsuyuki MIKI１, Yojiro KATO１, Tetsuya BABAZONO２ and Shohei FUCHINOUE１
１Department of Surgery, Kidney Center, Tokyo Women’s Medical University
２Diabetes Center, Tokyo Women’s Medical University
As of February 2018, 333 pancreatic transplantations from brain-dead donors have been performed in Japan.
Of these, 63 were performed at our institution between January 2001 and February 2018. Simultaneous pancreas
and kidney transplantation (SPK) was performed in 54 patients and pancreas after kidney transplantation (PAK)
was performed in 9 patients. The operative time was significantly longer for SPK than for PAK (SPK 390 min,
PAK 266 min: p = 0.00016). Transplanted pancreas graft loss occurred in 9 of 54 SPK cases (16.7%), and in 5 of 9
PAK cases (55.6%). The causes of graft loss were thrombosis, rejection, infection, recurrence of type1 diabetes,
and pancreatitis. The 1-, 3-, 5-, and 10-year pancreatic graft survival rates for SPK were 92.3%, 87.7%, 83.1%, and
71.1%, respectively, and the 1-, 3-, and 5-year pancreatic graft survival rates for PAK were 55.5%, 55.5%, and
37.0%, respectively. Both of pancreatic and renal graft survival rates in our institution were higher than those of
US/non-US and Japan. The patient survival rate was also higher in our institution. As pancreatic transplantation
is currently considered the optimal treatment for type 1 diabetic patients, improvement of graft survival is an ur-
gent issue.
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Fig.　1　Annual number of pancreatic transplants performed in Japan and our institution 
as of February 2018
As of February 2018, 333 and 63 pancreatic transplants from brain-dead donors have 
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（Fig. 1）．膵臓移植は国内ではここ 3年の間に 2015



















ous pancreas and kidney transplantation：SPK）54
例，腎移植後膵臓移植（pancreas after kidney trans-
plantation：PAK）9例であった．膵単独移植（pan-





























Table　1　Clinical characteristics of pancreatic transplant patients
SPK＊ (n＝54) PAK＊＊ (n＝9) p value
Age of recipient (y) 44.1±5.8 42.2±4.9 0.54
Sex of recipient (male/female) 18/36 2/7 0.51
Age of donor (y) 38.9±9.5 33.4±9.5 0.22
Sex of donor (male/female) 32/22 3/6 0.15
BMI＊＊＊of donor (kg/m2) 21.5±2.8 20.4±2.9 0.31
Operative time (min) 389±64 266±56 0.00016
Bleeding volume (g) 665±596 563±618 0.26
TIT＊＊＊＊of pancreatic graft (min) 601±80 580±74 0.52
Exocrine drainage (ED/BD＊＊＊＊＊) 34/20 4/5 0.29
Enteric conversion 9 0 0.22
Observation period (months) 59 (3-387) 69 (2-145) 0.50
Operative time was significantly longer for SPK than for PAK.
＊SPK: simultaneous pancreas and kidney transplantation, ＊＊PAK: pancreas after 
kidney transplantation, ＊＊＊BMI: body mass index, ＊＊＊＊TIT: total ischemic time, 
＊＊＊＊＊ED/BD: enteric drainage/bladder drainage.
例，女性 43例，平均年齢 44歳，SPK54例，PAK9
例であった．SPKと PAKの症例の詳細を Table 1
に示す．手術時間は，SPK平均 6時間 29分，PAK
























































63例中 2例が死亡した．死亡した 1例は PAKで，
23
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Fig.　2　Pancreatic graft survival rate at our institution: SPK vs. PAK as of February 2018
The 1-, 3-, 5-, and 10-year pancreatic graft survival rates for SPK are 92.3%, 87.7%, 83.1%, 
respectively, and 71.1%, and the 1-, 3-, and 5-year pancreatic graft survival rates for PAK 
are 55.5%, 55.5%, and 37.0%, respectively.
Graft survival 1-year 3-year 5-year 10-year
SPK
% 92.3 87.7 83.1 71.1
n 46 29 18 3
PAK
% 55.5 55.5 37.0
n 6 6 3
SPK (n=54)
PAK (n=9)
Table　2　Causes of pancreatic graft loss
Pancreatic graft loss at our institution as of February 2018
Cause of graft loss SPK (n＝54)
Infection 3 (5.6%)
Chronic rejection 2 (3.7%)
Recurrence of diabetes 2 (3.7%)
Acute rejection 1 (1.9%) 
Pancreatitis 1 (1.9%) 
Total  9 (16.7%) 
Pancreatic graft loss in Japan as of February 20184)
Cause of graft loss SPK (n＝232)
Thrombosis 12 (5.2%)
Chronic rejection  4 (1.7%)
Recurrence of diabetes  4 (1.7%)
Acute rejection  2 (0.9%)
Duodenal perforation  2 (0.9%)
Duodenal bleeding  1 (0.4%)
Death 12 (5.2%)
Total  36 (15.5%) 
The graft loss rate for SPK was 16.7% at our institution and 15.5% in Japan. The graft loss rate 
for PAK was 55.6% at our institution and the rate for PAK/PTA in Japan was 44.2%.
SPK: simultaneous pancreas and kidney transplantation, PAK: pancreas after kidney transplan-
tation, PTA: pancreas transplantation alone.
Cause of graft loss PAK (n＝9)
Thrombosis 4 (44.4%)
Chronic rejection 1 (11.1%)
Total 5 (55.6%)
Cause of graft loss PAK/PTA (n＝52)
Chronic rejection 12 (23.1%)
Recurrence of diabetes 4 (7.7%)
Thrombosis 3 (5.8%)






Fig.　3　Renal graft survival rates for SPK at our institution as of February 2018
The 1-, 3-, 5-, and 10-year renal graft survival rates for SPK were 98.0%, 95.5%, 91.5%, and 
91.5%, respectively.
Graft survival 1-year 3-year 5-year 10-year
% 98.0 95.5 91.5 91.5
n 48 30 20 3
移植 4年後に脳腫瘍にて手術を行ったが，その後 2














当教室で比較した．United Network of Organ Shar-
ing（UNOS）/ International Pancreas Transplant
Registry（IPTR）の報告２）によると，2010年から 2014
年の全世界の膵臓移植 4,197例のうち SPKは 3,762
































数は 65名であり，国内の膵臓移植希望者の 3分の 1
25
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Table　3　Pancreatic and renal graft survival rates and patient sur-
vival rates
1-year 3-year 5-year
Pancreatic graft survival rate for SPK
US/non-US (n＝3,762) 89.1% 82.2%
Japan (n＝232) 87.5% 86.4% 82.8%
Our institution (n＝54) 92.3% 87.7% 83.1%
Pancreatic graft survival rate for PAK
US/non-US (n＝435) 84.4% 75.4%
Japan (n＝37) 86.5% 64.5% 48.8%
Our institution (n＝9) 55.5% 55.5% 37.0%
Renal graft survival rate for SPK
US/non-US (n＝3,757) 95.5% 88.5%
Japan (n＝232) 94.2% 94.2% 90.8%
Our institution (n＝54) 98.0% 95.5% 91.5%
Patient survival rate
US/non-US (SPK: n＝3,707) 96.3% 97.9%
(PAK: n＝439) 94.9% 94.5%
Japan (n＝232) 96.3% 95.8% 95.2%
Our institution (n＝54) 100.0% 100.0% 100.0%
Comparison between US/non-US, Japan, and our institution
US/non-US: (January 2010-December 2014)2); Japan: (April 2000-December 
2016)4); our institution: (January 2001-February 2018)
Pancreatic and renal graft survival rates for SPK and patient survival 
rates at our institution were superior to those in the US/non-US and Ja-
pan. On the other hand, the pancreatic graft survival rate for PAK at our 
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